A comprehensive view of eli lilly & co.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Australia Patent: Eli Lilly and Co. Files Application for 'Systems and methods for displaying patient data'
Published:
May 17, 2024
by Australian Government
|
Australia: Eli Lilly and Co. Receives Patent for 'Compounds and methods targeting human tau'
Published:
May 17, 2024
by Australian Government
|
Australia Patent: ELI LILLY AND Co., NEKTAR THERAPEUTICS File Application for 'DOSING REGIMENS FOR SELECTIVE TREG STIMULATOR RUR20KD-IL-2 AND RELATED COMPOSITIONS'
Published:
May 17, 2024
by Australian Government
|
Australia: Eli Lilly and Co. Receives Patent for 'Status sensing systems within an injection device assembly'
Published:
May 17, 2024
by Australian Government
|
Australia Patent: ELI LILLY AND Co. Files Application for 'HUMAN TUMOR NECROSIS FACTOR ALPHA ANTIBODIES'
Published:
May 17, 2024
by Australian Government
|
Ask us about our Health Care Sector market view